Public Advisory Panels Recommend Regulatory Adjustments – Strategic Implications for Biotech Oversight
Public advisory panels increasingly influence how health regulators evaluate emerging therapies, safety signals, and complex scientific evidence. These independent bodies, often composed of clinicians, researchers, patient advocates, and policy experts, provide structured recommendations that help regulatory agencies refine their decision-making processes. When panels recommend regulatory adjustments, their guidance can reshape approval pathways, post-market surveillance strategies, … Read more